A Pharmaceuticals and Healthcare (Diagnostic Imaging Centres) entity from India is looking to sellout.

Posted By - Investment Banker

BUSINESS BRIEF

A leading molecular diagnostic service business strategically headquartered in New Delhi is looking to sell out. The business also provides pathological services and various testing facilities including tests for infectious diseases, cancer, metabolic diagnostic, prenatal diagnostic, genetic disorder etc. The facility does more than 7500 tests every month. Also, the facility equipments are USFDA and CE approved. Providing its services in various locations like Delhi, Faridabad, Gurgaon, Uttar Pradesh and Rajasthan

Proposal

Dealsize IconDeal Size INR 150 to 200 Mn
Justification:
Motives For Sellout Strategic Realignment
Industry Icon

Industry

Pharmaceuticals

Subindustry Icon

Sub-Industry

Diagnostic Imaging Centres

Management is open to continue with the business for handholding the new investor/buyers

Business Operating Information

Industry Icon Industry: Hospitals and Healthcare

Industry Icon Sub-Industry: Diagnostic Imaging Centres

Division

Division`s Buyers/Customers

Division`s Plant Location

Financial Information

2017 (in INR) 2018 (in INR) 2019 (in INR) 2020 (in INR)
Sales N.D N.D 30 Mn 48 Mn
EBDITA
PAT
TANGIBLE NET WORTH N.D N.D N.D N.D
LONG TERM DEBT N.D N.D N.D N.D
TOTAL DEBT N.D N.D N.D N.D

Business Document

Business Model

CONTACT BUSINESS

If you are interested in connecting with business please send an Expression of Interest.

SHARE VIA
CONTACT DETAILS